#Texas Cardiac Arrhythmia Institute #cardiac arrhythmias #EPLive 2026

Celebrating Cardiac Health: EPLive 2026

The Texas Cardiac Arrhythmia Institute (TCAI), part of St. David’s Medical Center, is gearing up to host its eighth international symposium on complex cardiac arrhythmias on May 28-29, 2026. This acclaimed conference, known as EPLive, convenes every two years, bringing together top global experts in cardiac electrophysiology for an intensive two-day educational experience.

What to Expect at EPLive 2026

EPLive 2026 will focus on the pressing issue of managing complex arrhythmias—conditions characterized by irregular heart rhythms—in a clinical setting. It targets healthcare professionals, including physicians, advanced practice nurses, and paramedics who are eager to enhance their understanding and skills in this area. The symposium will feature live clinical cases broadcasted from TCAI’s state-of-the-art Electrophysiology Center, allowing participants to engage with real-world scenarios while receiving expert commentary.

Dr. Andrea Natale, a prominent figure in cardiac electrophysiology and the executive medical director at TCAI, expresses enthusiasm about the upcoming event: "EPLive 2026 will serve as a pivotal platform for the global electrophysiology community to engage in real-time learning through complex case-based training. Our unique approach blends live procedures with expert discussions, offering a highly impactful hands-on experience."

Innovative Treatment Approaches

This year’s discussions will spotlight a more streamlined approach that combines two common treatments—Atrial Fibrillation (AF) and Left Atrial Appendage (LAA) occlusion—in one procedure. This innovative method not only simplifies treatment for patients at higher stroke risk but also enhances efficiency in intervention times. By addressing both the abnormal heart rhythm and a frequent stroke risk factor simultaneously, healthcare providers can improve safety and patient outcomes.

With a robust agenda featuring four main sessions on AF ablation, ventricular tachycardia ablation, LAA occlusion cases, and new device technologies, attendees will benefit from a wealth of information gleaned from both live demonstrations and recorded cases from renowned electrophysiology centers worldwide, including prestigious institutions in Belgium, Canada, Colombia, Italy, and across the United States.

Educational Goals and Benefits

EPLive 2026 is designed not just as a conference but as an educational journey with clear goals:

• - Identify processes aimed at reducing complications and enhancing patient safety during AF ablation and other cardiac arrhythmias.
• - Demonstrate familiarity with the latest evidence and guidelines in arrhythmia management using advanced technologies.
• - Apply strategies to fully leverage new technologies for clinical outcomes optimization.
• - Assess processes that can benefit from integrating new technologies to foster safer patient procedures.
• - Reflect on practices leading to better outcomes in the extraction of leads from complex cardiac implants.

High-profile TCAI physicians, including course co-directors Amin Al-Ahmad, Luigi DiBiase, and **Dhanunjaya